Certificate of Supplementary Protection Regulations, SOR/2017-165
Section 6
Countries and period
Cite as Certificate of Supplementary Protection Regulations, SOR/2017-165, s. 6 · current to July 24, 2025 · regulation last amended January 1, 2025
Statute Watch
Get an alert when a bill in Parliament would change this section, and every time it moves.
The text
(1) For the purpose of paragraph 106(1)(f) of the Act,
(a) the prescribed countries are
(i) the European Union and any country that is a member of the European Union,
(ii) the United States of America,
(iii) Australia,
(iv) Switzerland,
(v) Japan, and
(vi) the United Kingdom; and
(b) the prescribed period for filing the application for the authorization for sale is
(i) 24 months, if the application for a certificate of supplementary protection was filed no later than the first anniversary of the day on which section 59 of the Canada–European Union Comprehensive Economic and Trade Agreement Implementation Act comes into force, and
(ii) 12 months, in any other case.
(2) For the purpose of subsection 106(3) of the Act, the prescribed period for filing the application for a certificate of supplementary protection is 120 days.
(3) An application for a certificate of supplementary protection must contain
(a) the applicant’s name and contact information in Canada, including their complete address;
(b) the filing date of the application for the patent, the date on which the patent was granted and the date on which the term referred to in section 44 of the Act will expire;
(c) the applicant’s attestation, as the case may be, that the applicant is the patentee and is recorded as an owner of the patent in the Patent Office or that they are the manufacturer who is authorized under section 8 to file the application;
(d) the applicant’s attestation that
(i) when the application was filed for the authorization for sale referred to in paragraph 106(1)(c) of the Act, no application for a marketing approval, equivalent to an authorization for sale, with respect to the medicinal ingredient or combination of medicinal ingredients, as the case may be, set out in the application for the certificate of supplementary protection had been submitted in a country prescribed by paragraph (1)(a), or
(ii) if one or more of those applications for a marketing approval had been submitted in one or more of those countries, the application for the authorization for sale referred to in paragraph 106(1)(c) of the Act was filed before the end of the prescribed period referred to in paragraph (1)(b) that begins on the day of submission of the first of those marketing approval applications; and
(e) a description of the method of payment used to pay the fee prescribed under subsection 9(1).
Read the Certificate of Supplementary Protection Regulations on the Justice Laws Website ↗
Made under Patent Act, R.S.C. 1985, c. P-4.
Bills in Parliament that would change this section 0
No bill we hold would amend or repeal this section.